Molly M. Stevens FREng FRS

Professor of Biomedical Materials and Regenerative Medicine at Imperial College London

Regenerative medicine, biosensing, therapeutics


BA - Bath University, UK

PhD - University of Nottingham, UK

Postdoctoral Fellow – MIT, Boston, MA


Fellow of The Royal Society, 2020

Foreign Member of the National Academy of Engineering, 2019

Harrison Medal, Royal Pharmaceutical Society, 2017

Imperial College President’s Award and Medal for Outstanding Research Team, 2016

Rosenhain Medal and Prize, IOM3, 2010

ACES Amgen Life Sciences Award, Science Business Innovation Board, 2009

Jean Leray Award, European Society for Biomaterials, 2009

Science Medal, Royal Pharmaceutical Society of Great Britain, 2006

Rectors Award for Excellence, Imperial College London, 2005

TR100 (Top 100 Young Innovators), Technology Review, 2004


Co-Founder: RepRegen, SPARTA Biodiscovery, Signatur Biosciences

Board of Directors:

NED of Signatur Biosciences, Sparta Biodiscovery and Nanovation Therapeutics, Board of Trustees for the National Gallery (London).

Scientific Advisory Board:

Rosalind Franklin Institute, NanoCell, OMeat, Hoxton Farms, Multus Media, BaseImmune, Origin Sciences, TYBR Health, Tower CellX, 30 Tech, CipherX Technologies

MEMBER OF Investment Committee

Associated Portfolio Companies

No items found.